The purpose of this study was to evaluate the effect of calcium antagonists on basal tension and the elevated 
A lthough multiple factors are involved in the pathogenesis of hypertension, it has become apparent that functional changes in vascular smooth muscle (VSM) are important to the etiology of this disease. One reflection of this alteration is the increase in the steady-state turnover of potassium, 1 
"
4 which develops during the prehypertensive stage of both genetic and mineralocorticoid-salt models of hypertension. 5 It has been proposed that this elevated K + efflux reflects a general increase in membrane permeability caused by a decrease in membrane-bound calcium observed in vascular tissue. 36 -
The presence of calcium-dependent potassium channels has been identified in several tissues, 10 n but the demonstration of these channels in smooth muscle has been relatively recent. 12 -14 These channels are normally closed at the resting level of intracellular calcium. 1516 However, stimulation of VSM by an agonist elevates the intracellular calcium concentration, which initiates contraction and opens calcium-dependent potassium channels. 1214 Reports of depolarization, 17 " 19 increased calcium influx, 20 and elevated intracellular calcium 21 in VSM from hypertensive rats suggested that calcium entry through potential-operated calcium channels may support the elevated potassium efflux through this pathway. The purpose of our study was to evaluate the effect of calcium antagonists on the basal Palo Alto, California) was implanted subcutaneously. Each rat was given a 1% NaCl solution (supplemented with 0.3% KC1 to maintain potassium balance in rats that received aldosterone) to drink. The daldosterone (Sigma Chemical Co., St. Louis, Missouri) was dissolved in polyethylene glycol and was infused at a rate of 0.25 /tg/hr for a minimum of 2 weeks (most rats were studied at 4 weeks). This protocol produced a significant elevation in systolic blood pressure, which was determined by a tail-cuff method. 4 Each AHR had a minimum systolic pressure of 180 mm Hg. Control-salt (CS) rats were unilaterally nephrectomized and given a 1% NaCl solution to drink. Previous experiments indicated that vehicle infusions did not produce detectable differences in blood pressure, 4 so infusions of the vehicle were omitted. The average systolic pressure of CS rats was 120 mm Hg. Rats were decapitated and the thoracic aorta quickly removed and placed in low calcium (0.25 mM Ca 2+ ) dissection solution. For experiments involving 42 K, the dissection solution was also K + free to reduce endogenous potassium in preparation for 42 K equilibration. Loose connective tissue and fat were dissected from the vessel, which was then slit lengthwise. After endothelial cells were removed from the strips by lightly stroking the intimal surface with moistened filter paper, the vessel was cut in half and mounted on a stainless steel holder.
Solutions
Normal Potassium efflux. These procedures were published previously 2 and evaluated. 22 The tissues were incubated for 2.5-3 hours at 37° C in physiological solution containing 42 K (20 ju,Ci/ml) (University of Missouri Reactor, Columbia, Missouri). After a 2-second rinse, each tissue was passed through a series of vigorously gassed tubes containing nonradioactive physiological solution. After 40 minutes, the calcium antagonist diltiazem or nisoldipine was included in the physiological solution. Preliminary experiments indicated that 15 minutes was sufficient to reach a maximal response to the calcium antagonist. Also, the dose-response curve derived from cumulative addition of a calcium antagonist to one strip was similar to that derived from exposure of individual strips to one concentration each. The more efficient protocol was adopted in which the tissues were exposed to each concentration of the antagonist for three consecutive 5-minute collection periods and then passed into tubes that contained the next higher concentration. Preliminary studies determined that the basal 42 K efflux from aorta of AHR was stable for the duration of the experiment so a time correction factor was unnecessary. Because nisoldipine is light sensitive, all nisoldipine experiments were done in subdued light.
A y spectrophotometer (Packard Instruments Co., Inc., Downers Grove, Illinois) was used to count 42 K activity. Washout curves and rate constants (/c/min) were calculated as reported previously on an IBM personal computer (Boca Raton, Florida). 4 The rate constants at the 20-40-minute periods were used to determine steady-state turnover for statistical comparisons. To calculate the response to the antagonist (M/min), the basal rate constant was subtracted from the rate constant obtained during the third collection period (10-15-minute exposure) at each antagonist concentration. The response to each concentration of antagonist (Ak), was normalized in terms of the maximal response to the antagonist (M max) and represented as a percentage. The median inhibitory concentration (IC 50 ) was determined for each tissue by linear interpolation between the log concentration just below and just above the 50% response.
45 Ca influx. Each half of an aorta was mounted on a holder, and the tissue was incubated for 2-3 hours at 37° C in a modified physiological solution with Ca 2+ =1.25 mM and H 2 P(V=0. During the last 20 minutes of incubation, one half aorta was placed in a similar solution that contained diltiazem. Each half aorta was then placed in modified physiological solution (± diltiazem) that contained 45 Ca (5 /zCi/ml, New England Nuclear, Boston, Massachusetts). The influx was quickly terminated after 90 seconds by placement of the tissues in cold (1° C) wash solution (in which the Ca 2+ =5 mM and PO 4 =0) for 30 minutes. At the end of the wash period, the tissues were dried for 2 hours at 110° C and then weighed. The Ca was released by addition of 0.5 ml H 2 O 2 (30% wt/vol) followed by a 10-minute microwave treatment. The sample was extracted into a 0.1 M HN0 3 solution for 10 minutes, neutralized with IN NaOH, and diluted into 10 ml scintillation cocktail. Standards were prepared similarly. The 
Contraction
The thoracic aorta employed for contraction was treated similarly to that used for 42 K efflux studies and was placed in low Ca 2+ , potassium-free dissection solution and cleaned of fat and loose connective tissue. The aorta was then cut into rings (3.5 mm wide, 0.14 mm thick), and the endothelium was removed by lightly stroking the intimal layer with moistened filter paper. The rings were stretched one third of their resting diameter by means of a micrometer mounted on a force transducer. The tissue was placed in a vigorously gassed physiological solution maintained at 37° C and equilibrated for 90 minutes. Successively higher concentrations of the antagonist were added cumulatively to the bath. The tissue was exposed to each concentration of antagonist for a minimum of 10 minutes or until the contractile response reached a plateau. The tension recorded during the plateau was used in the calculation of the IC 50 .
Statistics
The IC 50 values calculated for 42 K efflux and tension studies were converted to log values for statistical comparison using the Student's t test. Results are presented as the geometric mean ± SEM. A paired t test was used to evaluate the effect of diltiazem on 45 Ca influx. Ap<0.05 was required for significance.
Results

Diltiazem and
42
K Efflux
The effect of diltiazem on basal 42 K efflux in aorta from AHR and CS rats is presented in Figure 1 . Ca influx in aorta from either AHR or CS rats (data not shown).
Diltiazem and Contraction
Seventy percent of the aortic rings from AHR spontaneously developed basal tension, which was commonly (70-80%) associated with phasic contractile activity (Figure 3) . The remaining 30% of AHR aorta did not develop any spontaneous tonic contractions. When present, the basal tension was relaxed a total of 2.0±0.4 g by diltiazem (Figure 3 ). Subsequent incubation of these tissues in 0 calcium/2 mM EGTA physiological solution produced no additional relaxation. Neither diltiazem nor 0 calcium solution altered the tension in CS rat aortic rings. The concentrationresponse curve for diltiazem inhibition of contraction was to the left of that for 42 K efflux, as shown in Figure 4 . The diltiazem IC 50 for contraction (0.04±0.02 nM) was significantly lower than the IC 50 for 42 K efflux (0.22±0.08 tiM,p<0.01).
Nisoldipine and 42 K efflux
It was reported that some potassium channels were directly blocked by a calcium antagonist. 24 Therefore, a class of calcium antagonist was studied that differed 
Nisoldipine and Contraction
Nisoldipine eliminated the phasic contractile activity and relaxed the basal tension a total of 2.7 ±0.5 g in aortic rings from AHR. The IC 50 for nisoldipine was 0.016±0.01 nM. No additional change in contractile response occurred when the aortic rings were subsequently placed in 0 calcium/2 mM EGTA physiological solution. Neither nisoldipine nor 0 calcium solution altered the tension in CS rat rings. The concentration-response curve for nisoldipine inhibition of contraction was to the left (160-fold) of that for 42 K efflux, as shown in Figure 6 .
Nisoldipine and KCl Stimulation
We wished to determine whether depolarizationstimulated contraction and 42 K efflux from CS rat aorta exhibited a similar difference in sensitivity to nisoldipine, or whether the difference was specific to 
Discussion
Our results suggest that 75-85% of the elevation in basal potassium efflux was secondary to increased calcium entry into the AHR aorta. Two types of calcium antagonists, diltiazem and nisoldipine, reduced the elevated potassium efflux as well as spontaneous contraction toward control values. It is likely that diltiazem and nisoldipine decreased potassium efflux in aorta from AHR by inhibition of calcium entry through potential-operated calcium channels (POC) because calcium antagonists do not alter resting calcium entry through "leak" channels, 25 -26 and at the IC 50 for inhibition of basal K + efflux in AHR, they selectively block calcium entry through POC and not through other channels. VSM 25 -29 was shown to increase potassium efflux as well. 30 Both calcium entry and potassium efflux from control VSM were inhibited by concentrations of diltiazem (IC 50 =0.6 yM) and nisoldipine (IC 50 =2 n M)26,27,3o equivalent to those that inhibited the basal potassium efflux in AHR aorta (diltiazem IC 50 =0.2 /JM, nisoldipine IC 50 =1.8 nM). Likewise, the nisoldipine IC 50 was similar to the binding constant for single POC in VSM. 31 The basal 45 Ca influx in AHR (but not CS rats) was also inhibited by diltiazem, although at a higher IC 50 than potassium efflux. (This shift may reflect technical limitations for the detection of small changes in calcium influx with our method). Because activation of POC normally requires depolarization, 31 these results imply that the membrane potential in AHR aorta was less polarized than that in CS rat aorta or that the POC exhibited a different dependence on membrane potential. No measurements are available of resting membrane potential in VSM from AHR, and measurements in spontaneously hypertensive rats were inconsistent, with reports of a decrease 17 or no change. 32 Verification that the AHR aorta is depolarized or that POC in AHR behave differently at a normal membrane potential will require detailed electrophysiological study.
Although our studies were not sufficiently detailed to identify the type of channels underlying this response, the slow type of POC and a calciumdependent potassium channel are likely candidates. Although both fast and slow calcium channels have been identified in VSM, 31 the greater sensitivity of the slow channel to calcium antagonists would suggest that activation of slow channels underlies the increased diltiazem-sensitive calcium influx in the AHR aorta. Many potassium channels have been identified in mammalian tissues. 33 However, the identification of calcium-dependent potassium channels in rat aorta, 1430 and the high sensitivity of basal potassium efflux in AHR to calcium antagonists suggest that calcium-dependent potassium channels mediate most of the increased potassium efflux in AHR. It is unknown whether the elevation in residual potassium efflux from AHR aorta exposed to nisoldipine (1 fiM) resulted from incomplete block- Figure 4 .
ade of calcium entry or from abnormal function of a calcium-independent potassium channel. The identification of the particular types of potassium channel will again require detailed electrophysiological study.
Spontaneous tension that developed in most aorta from AHR was eliminated by diltiazem and nisoldipine and therefore appeared to result from calcium entry via POC. Similar findings were observed in arteries from spontaneously hypertensive rats. 34 -35 Our previous studies on control rats indicated that the calcium-dependent potassium efflux and contraction were closely correlated. 1430 Therefore, it was expected that basal tension and potassium efflux in AHR would exhibit similar sensitivity to calcium antagonists. However, a sevenfold (diltiazem, Figure  4 ) to 160-fold (nisoldipine, Figure 6 ) difference in sensitivity existed between these two measures that was attributable mainly to a supersensitivity of the basal tension to calcium antagonists. For example, the diltiazem and nisoldipine IC 50 for inhibition of basal potassium efflux in AHR was similar to that for KCl-stimulated potassium efflux from CS rats, whereas the IC 50 for inhibition of basal tension in AHR was 10-37-fold less than that for inhibition of KClstimulated contraction in control rat aortas ( Figure  7) . 30 The reason for the increased sensitivity of basal tension in AHR to calcium antagonists is not readily apparent. Actions on sites other than POC require much higher concentrations. 36 -38 Although inhibitory effects of a dihydropyridine were observed on chemically skinned aorta from spontaneously hypertensive rats, 39 contributions from residual POC may not have been eliminated. McMahon and Paul 40 had to modify the skinning procedure significantly to overcome this problem for studies of rat aorta.
In conclusion, this investigation demonstrated that spontaneous tension and elevation of basal potassium efflux developed in aorta from AHR and that both processes could be returned toward control levels by the calcium antagonists diltiazem and nisoldipine. The altered functions appeared to be second-ary to increased calcium entry via POC. Basal tension was more sensitive to inhibition by calcium antagonists than potassium efflux, but the mechanisms remain to be elucidated.
